Publicaciones en colaboración con investigadores/as de Maastricht University (20)

2023

  1. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 1, pp. 48-56

  2. Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review

    Seminars in Arthritis and Rheumatism, Vol. 58

2022

  1. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): Systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

    RMD Open, Vol. 8, Núm. 2

  2. Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

    RMD open, Vol. 8, Núm. 1

  3. Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 10, pp. 1344-1347

  4. Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs

    RMD open, Vol. 8, Núm. 1

2021

  1. Identification of a distinct lipidomic profile in the osteoarthritic synovial membrane by mass spectrometry imaging

    Osteoarthritis and Cartilage, Vol. 29, Núm. 5, pp. 750-761

2020

  1. EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 11, pp. 1423-1431

  2. Integrative metabolic pathway analysis reveals novel therapeutic targets in osteoarthritis

    Molecular and Cellular Proteomics, Vol. 19, Núm. 4, pp. 574-588

2018

  1. 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 77, Núm. 4, pp. 476-479

2017

  1. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 960-977

  2. Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: A discrete choice experiment among European rheumatologists

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 1, pp. 126-132

  3. MALDI mass spectrometry imaging in rheumatic diseases

    Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1865, Núm. 7, pp. 784-794

2016

  1. Gla-rich protein is involved in the cross-talk between calcification and inflammation in osteoarthritis

    Cellular and Molecular Life Sciences, Vol. 73, Núm. 5, pp. 1051-1065

  2. Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: A EULAR initiative

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 6, pp. 965-973

2014

  1. Multinational evidence-based recommendations for the diagnosis and management of gout: Integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 2, pp. 328-335

  2. The efficacy and safety of treatments for acute gout: Results from a series of systematic literature reviews including cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors

    Journal of Rheumatology, Vol. 41, Núm. SUPPL. 92, pp. 15-25

2012

  1. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  2. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196

2010

  1. Current evidence for the management of rheumatoid arthritis with glucocorticoids: A systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 6, pp. 1010-1014